UTI-lizer
Utilizer is a Swedish medtech startup dedicated to developing point-of-care diagnostic tests for urinary tract infections (UTIs). Their innovative technology aims to provide fast, accurate, and cost-effective bacterial testing, enabling decentralized diagnostics at various healthcare settings and even at home. Their mission is to decrease antibiotic overuse, improve patient quality of life through correct diagnoses, and reduce healthcare costs by bringing reliable UTI testing closer to patients.
Industries
Nr. of Employees
small (1-50)
UTI-lizer
Products
Miniaturized culture-based point-of-care UTI test (dipstick)
A dipstick-format miniaturized culture assay for urinary tract infection detection that uses chromogenic agar and phenotypic readout to identify common uropathogens and quantify bacterial concentration. Workflow: dip urine sample, incubate 5–8 hours, analyze with smartphone and optionally upload results to LIS/HIS. Reported to identify the five most common urinary pathogens and provide a clinically relevant quantification range.
Miniaturized culture-based point-of-care UTI test (dipstick)
A dipstick-format miniaturized culture assay for urinary tract infection detection that uses chromogenic agar and phenotypic readout to identify common uropathogens and quantify bacterial concentration. Workflow: dip urine sample, incubate 5–8 hours, analyze with smartphone and optionally upload results to LIS/HIS. Reported to identify the five most common urinary pathogens and provide a clinically relevant quantification range.
Services
Design and execution of clinical performance and validation studies for point-of-care in vitro diagnostics, including site studies at regional hospitals and publication of results.
Design and execution of clinical performance and validation studies for point-of-care in vitro diagnostics, including site studies at regional hospitals and publication of results.
Expertise Areas
- Point-of-care diagnostic development
- Clinical validation and diagnostic performance
- Culture-based bacteriology for clinical diagnostics
- Microfluidics and device miniaturization
Key Technologies
- Miniaturized micro-culture dipstick (multi-well microplate)
- Chromogenic agar-based phenotypic assays
- Smartphone image analysis and digital readout
- Multiplexed bacterial detection
News & Updates
AMR Conference 2025 in Basel
Participation in the conference focused on antimicrobial resistance, emphasizing the role of diagnostics and the company's commitment to fighting AMR.
SWE-DEN Healthcare 2025
Participation in a healthcare innovation networking event in Copenhagen, engaging with stakeholders and promoting their diagnostic solutions.
Sting Day 2024
Networking and learning event for entrepreneurs and investors, showcasing the company's progress and innovations.
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Congress 2023
Presented their results on UTI diagnostics and decentralized testing at the congress.
Launch of new website
Announcement of the company's new website to showcase their journey and technology.
Published a study on miniaturized chromogenic bacterial cultivation for UTI diagnosis.
AMR Conference 2025 in Basel
Participation in the conference focused on antimicrobial resistance, emphasizing the role of diagnostics and the company's commitment to fighting AMR.
SWE-DEN Healthcare 2025
Participation in a healthcare innovation networking event in Copenhagen, engaging with stakeholders and promoting their diagnostic solutions.
Sting Day 2024
Networking and learning event for entrepreneurs and investors, showcasing the company's progress and innovations.
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Congress 2023
Presented their results on UTI diagnostics and decentralized testing at the congress.
Launch of new website
Announcement of the company's new website to showcase their journey and technology.
Published a study on miniaturized chromogenic bacterial cultivation for UTI diagnosis.